System for the combined delivery of nutraceuticals and drugs to combat cancer and viral infections

Abstract

A system for the intelligent, simultaneous delivery of nutraceuticals and drugs to combat cancer and viral infections, comprising: a dual reservoir assembly comprising a first reservoir configured to store at least one hydrophilic pharmaceutical compound under temperature-controlled and light-protected conditions, and a second reservoir configured to store at least one lipophilic nutraceutical compound in an inert gas-sealed environment; a microfluidic formulation unit fluidically coupled to the dual reservoir assembly, the formulation unit comprising: a controlled mixing interface for the simultaneous intake of pharmaceutical and nutraceutical liquids, a nanoprecipitation chamber with laminar flow connections and emulsification areas to form a nanocarrier with two compartments, an inner hydrophilic compartment and an outer lipophilic shell; a nanocarrier synthesis control module operatively coupled to the microfluidic formulation unit and configured to adjust flow rates, solvent selection, surfactant concentration, and polymer curing parameters based on formulation requirements; a biosensor interface configured to receive physiological data from at least one patient-wearable or implanted sensor module, the data including real-time measurements of biomarkers indicative of cancer progression, viral replication, immune response, or systemic toxicity; an adaptive formulation engine operatively connected to the nanocarrier synthesis control module and the biosensor interface, the formulation engine comprising a microcontroller executing a technique that dynamically adjusts formulation ratios, polymer composition, and release profiles based on the incoming physiological data and pre-installed treatment protocols; a multimodal delivery interface configured to deliver the synthesized nanocarriers via at least one of the following methods: a gastro-resistant capsule loader for oral use, a sterile injectable cartridge filler or a vibrating mesh atomizer for aerosolization; and a patient interface module configured to issue alerts, receive physician instructions, and log dosing history, with the system autonomously generating and delivering, in real time, biomarker-responsive nanocarrier formulations that combine nutraceutical and pharmaceutical active ingredients for a synergistic therapeutic effect.

Images